Stock NBY NOVABAY PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NovaBay Pharmaceuticals

Equities

NBY

US66987P3001

Market Closed - Nyse
Other stock markets
 01:30:00 04/05/2024 am IST 		5-day change 1st Jan Change
0.0949 USD +5.44% Intraday chart for NovaBay Pharmaceuticals +20.43% -53.48%
26/03 Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024
26/03 NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on NovaBay Pharmaceuticals

Price target over the last 5 years

History of analyst recommendation changes

ae325584aa319581786b6a17a47e.Gy4oyG-u-zMO7DYLKx9qAKsErTnmKzauRMz2WhNDRsA.cHheuFr2lgd7oUBtX0YHcf9W4nXQWWTEII2eHlcIPKNvYEG6O825QGCHdw~44c9ad8445d376a51b6753329765102d

Analyst Recommendations on NovaBay Pharmaceuticals

Ladenburg Thalmann Cuts Price Target on NovaBay Pharmaceuticals to $3.80 From $6, Maintains Buy Rating MT
NOVABAY PHARMACEUTICALS : Ladenburg Thalmann Adjusts NovaBay Pharmaceuticals PT to $2.20 From $1.90, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.0949 USD
Average target price
2.6 USD
Spread / Average Target
+2,639.73%
High Price Target
3.2 USD
Spread / Highest target
+3,271.97%
Low Price Target
2 USD
Spread / Lowest Target
+2,007.48%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NovaBay Pharmaceuticals

Ladenburg Thalmann

Ratings for NovaBay Pharmaceuticals

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Consensus NovaBay Pharmaceuticals